New Alzheimer's drug is first 'to target the root cause'

Kay Burley is joined by Research Information Manager at the Alzheimer's Society, Sian Gregory, who predicted that by 2025 their drug "could benefit at least 106,000 people in the UK".

The new drug called Lecanemab could slow the debilitating symptoms of the disease.